Purpose: To cross-culturally adapt and psychometrically analyse the Italian version of the Trunk Impairment Scale on acute (cohort 1) and chronic stroke patients (cohort 2).
Methods: The Trunk Impairment Scale was culturally adapted in accordance with international standards. The psychometric testing included: internal consistency (Cronbach’s alpha), inter- and intra-rater reliability (intraclass correlation coefficient; standard error of measurement and minimal detectable change), construct validity by comparing Trunk Impairment Scale score with Barthel Index, motor subscale of Functional Independence Measure, and Trunk Control Test (Pearson’s correlation), and responsiveness (Effect Size, Effect Size with Guyatt approach, standardized response mean, and Receiver Operating Characteristics curves).
Results: The Trunk Impairment Scale was administered to 125 and 116 acute and chronic stroke patients, respectively. Internal consistency was acceptable (α?>?0.7), inter- and intra-rater reliability (ICC >?0.9, Minimal Detectable Change for total score <?1.6 in cohort 1 and <?1.1 in cohort 2) were excellent. The construct validity showed acceptable correlations (r?>?0.4) with all scales but the motor Functional Independence Measure in cohort 2. Distribution-based methods showed large effects in cohort 1 and moderate to large effects in cohort 2. The Minimal Important Difference was 3.5 both from patient’s and therapist’s perspective in cohort 1 and 2.5 and 1.5 from patient’s and therapist’s perspective, respectively, in cohort 2.
Conclusion: The Trunk Impairment Scale was successfully translated into Italian and proved to be reliable, valid, and responsive. Its use is recommended for clinical and research purposes.
Implications for Rehabilitation
Trunk control is an essential part of balance and postural control, constituting an important prerequisite for daily activities and function.
The TIS administered in subjects with subacute and chronic stroke was reliable, valid and responsive.
The TIS is expected to help clinicians and researchers by identifying key functional processes related to disability in people with subacute and chronic stroke.
The EUropean REgistration of Cancer CAre (EURECCA) consortium aims to investigate differences in treatment and to improve cancer care through Europe. The purpose of this study was to compare neo- and adjuvant chemotherapy (ACT) and outcome after tumor resection for pancreatic adenocarcinoma stage I and II in the EURECCA Pancreas consortium.
Methods
The eight, collaborating national, regional, and single-center partners shared their anonymized dataset. Patients diagnosed in 2012–2013 who underwent tumor resection for pancreatic adenocarcinoma stage I and II were investigated with respect to treatment and survival and compared using uni- and multivariable logistic and Cox regression analyses. All comparisons were performed separately per registry type: national, regional, and single-center registries.
Results
In total, 2052 patients were included. Stage II was present in the majority of patients. The use of neo-ACT was limited in most registries (range 2.8–15.5%) and was only different between Belgium and The Netherlands after adjustment for potential confounders. The use of ACT was different between the registries (range 40.5–70.0%), even after adjustment for potential confounders. Ninety-day mortality was also different between the registries (range 0.9–13.6%). In multivariable analyses for overall survival, differences were observed between the national and regional registries. Furthermore, patients in ascending age groups and patients with stage II showed a significant worse overall survival.
Conclusions
This study provides a clear insight in clinical practice in the EURECCA Pancreas consortium. The differences observed in (neo-)ACT and outcome give us the chance to further investigate the best practices and improve outcome of pancreatic adenocarcinoma.
Firm conclusion about whether short and long-term gout medications use has an impact on cancer risk remain inconclusive. The aim of this study was to investigate the association between gout drugs use and risk of cancer.
Methods
We conducted a retrospective longitudinal population-based case-control study in Taiwan. Cases were identified all patients who were aged 20 years or above, and had a first time diagnosis of cancers for the period between 2001 and 2011. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) were calculated by using conditional logistic regression.
Results
We examined 601,733 cases and 2,406,932 matched controls. The adjusted odd ratio for any gout drugs use and overall cancer risk was 1.007 (95% CI: 0.994–1.020). There was a significant risk of leukemia (AOR: 1.34, 95% CI: 1.20–1.50), endometrial cancer (AOR: 1.33, 95% CI: 1.12–1.57), non-Hodgkin's (AOR: 1.24, 95% CI: 1.13–1.35), female breast cancer (AOR: 1.21, 95% CI: 1.13–1.29), cervical cancer (AOR: 1.21, 95% CI: 1.07–1.37). However, no association was observed in male group (AOR: 0.97, 95% CI: 0.95–0.98) but female showed a significantly increased risk of cancer at any site (AOR: 1.107, 95% CI: 1.08–1.13).
Conclusion
In summary, our results suggest that gout drugs increase risk of the most common cancers, particularly in leukemia, non-Hodgkin's, endometrial, breast and cervical cancer. 相似文献
Inflammation Research - Among the countless endeavours made at elucidating the pathogenesis of COVID-19, those aimed at the histopathological alterations of type 2 alveolar epithelial cells (AT2)... 相似文献
PurposeThe purpose of the study was to understand how adolescents concurrently use different modes of marijuana consumption.MethodsUsing data from the 2017 Healthy Kids Colorado Survey, we examined how modes of marijuana use (smoking/ingesting/vaping/dabbing/other) co-occur. We estimated the prevalence of all combinations of these modes among adolescents who reported past 30-day marijuana use (n = 3,618). We then estimated the prevalence of any use of each mode by each mode usually used.ResultsForty-one percent reported only smoking, another 10% reported smoking and dabbing, and 9.8% reported smoking and ingesting. Only about 10% used a combination of modes that did not include smoking. Smoking was the most common additional mode for all other usual modes of consumption.ConclusionsSmoking in combination with dabbing and/or ingesting were the most common multimode patterns of use. Nearly all adolescents who use marijuana smoke some or most of the time. 相似文献
Tics and obsessions-compulsions are consistent phenotypes of the Obsessive-Compulsive Tic Disorder (OCTD), frequently associated with male gender, sensory phenomena, and impulsive behaviors. These clinical symptoms were reported to influence eating behaviors, but literature also showed that food patterns or dietary supplements could alleviate the clinical spectra, thus suggesting the existence of a bidirectional association. We present a series of 9 boys with OCTD from Italy whose unhealthy food habits were corrected through a nutritional counseling. The education focused on promoting a balanced diet through non-specific Mediterranean dietary advices. After one month, YGTSS (Yale Global Tic Severity Scale) and Y-BOCS (Yale-Brown Obsessive Compulsive Scale) scored a significant reduction, but the quality of life diminished. First, we conclude that healthier dietary patterns may be associated with an amelioration of tics and obsessive-compulsive traits in boys who are diagnosed with the same conditions. Second, the impact of nutritional interventions on the quality of patients’ life, especially if underage, should always be considered. Certainly, the treatment of OCTD must be multidisciplinary and should include neuropsychiatrists, clinical psychologists, and nutritionists. The nutritional counseling should be as comprehensive as possible to promote a balanced diet, and inform about nutritional side effects of drugs or potential food-drug interactions. 相似文献